Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
This article was originally published in The Tan Sheet
Executive Summary
Germany’s Merck KGaA could join the ranks of firms like Pfizer potentially looking to leave the consumer health care product business, market analysts argue.
You may also be interested in...
Abbott Nutritionals Rise In Stature With Departure Of Branded Rx
Abbott Laboratories’ nutrition business – one of four divisions in the remaining diversified medical products firm – gains importance with the firm’s plan to spin off its research-based branded pharmaceuticals business.
Abbott Says Nutritionals Can Succeed Without M&A Activity
Abbott Laboratories executives say its nutritionals business is staying put and can succeed without mergers and acquisitions, despite dragging U.S. sales.
WIC Appropriations Woes Threaten Branded Formula Supremacy
Proposed appropriations cuts could threaten branded infant formulas’ strong competitive advantages.